Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arteris, Inc. stock logo
AIP
Arteris
$21.41
+2.2%
$22.23
$12.06
▼
$50.26
$1.05B1.9716,139 shs329,950 shs
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
$10.88
+0.0%
$10.83
$10.30
▼
$10.89
$264.05MN/A76,355 shs12,545 shs
Viant Technology Inc. stock logo
DSP
Viant Technology
$14.29
+1.1%
$12.74
$8.35
▼
$14.80
$949.60M1.11291,379 shs399,392 shs
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
$1.61
-0.9%
$1.75
$1.60
▼
$2.61
$871.90M0.531.09 million shs301,958 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arteris, Inc. stock logo
AIP
Arteris
+7.77%+6.02%-12.31%-22.29%+46.30%
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
-0.09%0.00%+0.32%+1.54%+5.33%
Viant Technology Inc. stock logo
DSP
Viant Technology
+2.24%+5.06%+15.91%+23.30%+55.62%
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
-0.61%-4.13%-4.13%-4.69%-31.23%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arteris, Inc. stock logo
AIP
Arteris
$21.41
+2.2%
$22.23
$12.06
▼
$50.26
$1.05B1.9716,139 shs329,950 shs
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
$10.88
+0.0%
$10.83
$10.30
▼
$10.89
$264.05MN/A76,355 shs12,545 shs
Viant Technology Inc. stock logo
DSP
Viant Technology
$14.29
+1.1%
$12.74
$8.35
▼
$14.80
$949.60M1.11291,379 shs399,392 shs
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
$1.61
-0.9%
$1.75
$1.60
▼
$2.61
$871.90M0.531.09 million shs301,958 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arteris, Inc. stock logo
AIP
Arteris
+7.77%+6.02%-12.31%-22.29%+46.30%
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
-0.09%0.00%+0.32%+1.54%+5.33%
Viant Technology Inc. stock logo
DSP
Viant Technology
+2.24%+5.06%+15.91%+23.30%+55.62%
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
-0.61%-4.13%-4.13%-4.69%-31.23%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arteris, Inc. stock logo
AIP
Arteris
2.71
Moderate Buy$37.2974.13% Upside
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
1.00
SellN/AN/A
Viant Technology Inc. stock logo
DSP
Viant Technology
3.13
Buy$18.3328.34% Upside
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
2.50
Moderate Buy$3.69129.91% Upside

Current Analyst Ratings Breakdown

Latest DMAA, AIP, DSP, and TUYA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/19/2026
Arteris, Inc. stock logo
AIP
Arteris
Lower Price TargetBuy$40.00 ➝ $25.00
10/16/2026
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
Reiterated RatingHold (C)
10/8/2026
Viant Technology Inc. stock logo
DSP
Viant Technology
UpgradeHold (C) ➝ Hold (C+)
10/5/2026
Viant Technology Inc. stock logo
DSP
Viant Technology
UpgradeStrong-Buy
9/21/2026
Arteris, Inc. stock logo
AIP
Arteris
Initiated CoverageBuy$30.00
8/26/2026
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
Reiterated RatingSell (D)
8/21/2026
Arteris, Inc. stock logo
AIP
Arteris
UpgradeSell (E+) ➝ Sell (D-)
8/21/2026
Viant Technology Inc. stock logo
DSP
Viant Technology
UpgradeHold (C-) ➝ Hold (C)
8/11/2026
Viant Technology Inc. stock logo
DSP
Viant Technology
Reiterated RatingMarket Outperform
8/11/2026
Viant Technology Inc. stock logo
DSP
Viant Technology
Boost Price TargetBuy$17.00 ➝ $19.00
8/11/2026
Viant Technology Inc. stock logo
DSP
Viant Technology
Boost Price TargetBuy$16.50 ➝ $17.50
(Data available from 10/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arteris, Inc. stock logo
AIP
Arteris
$84.62M12.44N/AN/A($0.33) per share-64.88
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
N/AN/AN/AN/AN/AN/A
Viant Technology Inc. stock logo
DSP
Viant Technology
$388.50M2.44$0.67 per share21.24$4.56 per share3.13
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
$321.79M2.71$0.11 per share15.13$1.89 per share0.85
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arteris, Inc. stock logo
AIP
Arteris
-$34.75M-$0.87N/AN/AN/A-46.70%-295.96%-22.26%11/5/2026 (Estimated)
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Viant Technology Inc. stock logo
DSP
Viant Technology
$8.35M$0.3146.08476.17N/A2.24%4.23%2.71%11/9/2026 (Estimated)
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
$57.89M$0.1114.5911.46N/A20.16%6.74%5.96%11/23/2026 (Estimated)

Latest DMAA, AIP, DSP, and TUYA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/23/2026Q3 2026
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
$0.03N/AN/AN/A$95.79 millionN/A
11/9/2026Q3 2026
Viant Technology Inc. stock logo
DSP
Viant Technology
$0.05N/AN/AN/A$66.16 millionN/A
11/5/2026Q3 2026
Arteris, Inc. stock logo
AIP
Arteris
-$0.04N/AN/AN/A$24.50 millionN/A
8/24/2026Q2 2026
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
$0.03$0.03N/A$0.03$87.83 million$92.93 million
8/14/2026Q2 2026
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
N/A$0.06N/A$0.06N/AN/A
8/14/2026Q2 2026
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
N/A$0.03N/A$0.03N/A$92.94 million
8/6/2026Q2 2026
Arteris, Inc. stock logo
AIP
Arteris
-$0.0416-$0.10-$0.0584-$0.30$23.48 million$24.13 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Arteris, Inc. stock logo
AIP
Arteris
N/AN/AN/AN/AN/A
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
N/AN/AN/AN/AN/A
Viant Technology Inc. stock logo
DSP
Viant Technology
N/AN/AN/AN/AN/A
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
N/AN/AN/AN/AN/A

Latest DMAA, AIP, DSP, and TUYA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/1/2100
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
$0.06053/18/20263/18/20264/21/2026
1/1/2100
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
quarterly$0.05409/11/20259/11/202510/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arteris, Inc. stock logo
AIP
Arteris
0.03
1.57
1.57
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
N/AN/AN/A
Viant Technology Inc. stock logo
DSP
Viant Technology
N/A
2.34
2.34
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
0.01
8.74
8.23

Institutional Ownership

CompanyInstitutional Ownership
Arteris, Inc. stock logo
AIP
Arteris
64.36%
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
N/A
Viant Technology Inc. stock logo
DSP
Viant Technology
11.38%
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
11.47%

Insider Ownership

CompanyInsider Ownership
Arteris, Inc. stock logo
AIP
Arteris
23.30%
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
0.90%
Viant Technology Inc. stock logo
DSP
Viant Technology
29.43%
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arteris, Inc. stock logo
AIP
Arteris
36449.15 million37.70 millionOptionable
Drugs Made In America Acquisition Corp. stock logo
DMAA
Drugs Made In America Acquisition
224.28 million24.06 millionN/A
Viant Technology Inc. stock logo
DSP
Viant Technology
47066.48 million46.91 millionOptionable
Tuya Inc. Sponsored ADR stock logo
TUYA
Tuya
1,441543.24 million531.83 millionOptionable

Recent News About These Companies

Tuya (TUYA) Forecasts Significant Operating Margin Expansion
Has Tuya (NYSE:TUYA) Fallen Enough To Trade At A Discount?
AI robot for seniors can call family after a fall
Tuya Inc. (TUYA)
Tuya Smart presenta Doova en la IFA 2026

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Arteris stock logo

Arteris NASDAQ:AIP

$21.41 +0.46 (+2.21%)
Closing price 03:59 PM Eastern
Extended Trading
$21.37 -0.04 (-0.18%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Arteris, Inc. provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP. Its products include FlexNoC and FlexWay silicon-proven interconnect IP products; Ncore, a silicon-proven and cache coherent interconnect IP product that provides scalable, configurable, and area efficient characteristics; and CodaCache, a last-level cache semiconductor IP product. The company also offers SIA products comprising Magillem Connectivity that shortens and streamlines the SoC integration process; and Magillem Registers and CSRCompiler that addresses hardware-software integration challenges for SoCs. The company serves semiconductor manufacturers, original equipment manufacturers, hyperscale system houses, semiconductor design houses, and other producers of electronic systems. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.

Drugs Made In America Acquisition stock logo

Drugs Made In America Acquisition NASDAQ:DMAA

$10.88 +0.01 (+0.08%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.

Viant Technology stock logo

Viant Technology NASDAQ:DSP

$14.28 +0.16 (+1.10%)
Closing price 03:59 PM Eastern
Extended Trading
$14.30 +0.01 (+0.07%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Viant Technology Inc. operates as an advertising technology company. It provides Household ID, a people-based innovation that combines digital and personal identifiers into a normalized household profile; AI Bid Optimizer, solution that uses AI to analyze historical bid opportunities to predict the lowest media cost for desired advertisement; and Viant Data Platform, which offers marketers control over their own data with actionable insights into their marketing initiatives within a single platform. The company also offers Holistic, an omnichannel DSP for marketers and their agencies to manage omnichannel campaigns and access metrics from each channel to inform decisions in other channels; Viant Identity Graph, which reduces or eliminates the need for cookies by enabling matching of people-based identifiers that anchor digital identifiers that allows marketers to reach targeted consumers in a privacy-conscious manner; and Direct Access, a path optimization program. In addition, it provides campaign analysis and data intelligence tool that empowers customers with differentiated insights, including conversion lift, multi-touch attribution, foot-traffic data reports, digital-out-of-home lift, sales reporting, and ROAS analytics; and self-service platform that provides customers with transparency and control over their advertising campaigns and underlying data infrastructure. The company sells its platform through a direct sales team focused on business development in various markets. It serves purchasers of programmatic advertising inventory; and large, independent, and mid-market advertising agencies, as well as marketers. The company was founded in 1999 and is headquartered in Irvine, California.

Tuya stock logo

Tuya NYSE:TUYA

$1.60 -0.02 (-0.93%)
Closing price 03:59 PM Eastern
Extended Trading
$1.60 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tuya Inc. offers purpose-built Internet of Things (IoT) cloud development platform in the People's Republic of China and internationally. The company provides platform-as-a-service that enables business, original equipment manufacturers, brands, and developers to develop, launch, manage, and monetize software-enabled smart devices and services; and industry software-as-a-service, which enables businesses to deploy, connect, and manage various types of smart devices. It also offers cloud-based software value-added services that provides end users with smart features, such as cloud storage; and Cube Smart Private Cloud Solution which enables conglomerates to build their own autonomous and controllable IoT platforms; and could-based services to businesses, developers, and end users to develop and manage IoT experiences. In addition, the company provides smart solutions for IoT devices that integrates software capabilities; and enables developers to activate an IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a range of smart devices, as well as sells finished smart devices. It offers its solutions to smart home, smart business, renewable energy, education, agriculture, outdoors and sport, and entertainment industries. The company was incorporated in 2014 and is based in Hangzhou, the People's Republic of China.